PerkinElmer SCID-SMA Kit Gets FDA Authorization
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Category: Immunoassay Reagents & test Kits
Immunoassay Reagents & test Kits
Latest
Immunoassay Reagents & test Kits
Latest
FDA Approves VENTANA MMR RxDx Panel
The U.S. Food and Drug Administration (FDA) has approved a label expansion for Roche's VENTANA MMR RxDx Panel.
Immunoassay Reagents & test Kits
Latest
Seegene Unveils COVID Testing Initiative to Help End Pandemic
Seegene unveiled a global initiative for preemptive and routine PCR COVID-19 testing to help individuals stay healthy during the pandemic.
FDA Grants Quanterix Breakthrough Device Designation for Multiple Sclerosis NfL Test
The NfL plasma test has been granted Breakthrough Device designation as a prognostic aid for patients diagnosed with relapsing-remitting MS.
Read More
New BD Assay Advances Immunology Research Capabilities of Multiomics
BD recently launched a set of reagents designed to enable researchers to more easily analyze important cells in the immune system.
Read More
Pangea Laboratory Donating 50K COVID Tests for the Uninsured
Pangea is donating 50,000 COVID-19 PCR tests, which have been made available for free to the uninsured in Los Angeles and Orange County.
Read More
Nanoparticles Could Enable More Sensitive & Durable Rapid COVID Tests
Researchers have developed a rapid test that uses molecularly imprinted polymer nanoparticles, rather than antibodies, to detect SARS-CoV-2.
Read More
Proof Diagnostics Seeks Emergency Use Authorization of CRISPER-Based POC COVID Test
Proof Diagnostics announced the submission of its EUA request for review to the U.S. FDA for its POC molecular diagnostic test for COVID-19.
Read More
Researchers Develop Highly Accurate, 30-Second COVID Test
Researchers have helped developed a COVID testing device that can detect infection in as little as 30 seconds as accurately as a PCR test.
Read More
Porvair Will Exhibit Specialist Assay Kits & Microplates at AACR 2022
Porvair Sciences will exhibit its latest assay kits and microplates for cancer and life science research at the 2022 AACR annual meeting.
Read More
Helix COVID Test with ‘Locker’ System Gets Emergency Use Authorization
Helix received FDA Emergency Use Authorization for its SARS-CoV-2 Test and Helix COVID-19 Self-Collection Kit.
Read More
Johns Hopkins Develops Sensor for Faster, More Accurate COVID Tests
The sensor requires no COVID-19 sample preparation and minimal operator expertise, offering a strong advantage over existing testing methods.
Read More
Visby Receives Federal Funding to Develop Rapid At-Home COVID & Flu Test
Visby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read More
COVID Saliva Tests are Quicker, Safer than Nasal Swabs
The research was motivated by urgent needs early in the pandemic to increase testing amid shortages of supplies, notably nasal swabs.
Read More
Avoid These Unauthorized COVID-19 Tests, FDA Says
The FDA recently issued three safety communications advising people to avoid using certain COVID-19 tests.
Read More
Influenza Home Tests as Accurate as Clinical Rapid Testing
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
Read More
New York Approves SQI Diagnostics’ New COVID Antibody Test
Access to the EXACT COVID-19 Antibody Test is available in the United States through AZOVA Inc, a telemedicine testing company.
Read More
FDA Authorizes On/Go One Compact, Rapid Antigen COVID Test
The new antigen test delivers results with 98.2% accuracy in 15 minutes and detects all major known variants, including Omicron, via an easy-to-use test.
Read More